ArticleInfectious diseases and therapy2021

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir.

Alessio Aghemo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.